sorafenib has been researched along with lysophosphatidic acid in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (lysophosphatidic acid) | Trials (lysophosphatidic acid) | Recent Studies (post-2010) (lysophosphatidic acid) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 1,950 | 17 | 1,116 |
| 6,520 | 730 | 5,251 | 19 | 0 | 3 |
| Protein | Taxonomy | sorafenib (IC50) | lysophosphatidic acid (IC50) |
|---|---|---|---|
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.4998 | |
| Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 | Homo sapiens (human) | 0.4709 | |
| Cocaine esterase | Homo sapiens (human) | 1.57 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Dalton, JT; Li, CM; Li, W; Lu, Y; Miller, DD; Wang, Z | 1 |
1 other study(ies) available for sorafenib and lysophosphatidic acid
| Article | Year |
|---|---|
Synthesis, in vitro structure-activity relationship, and in vivo studies of 2-arylthiazolidine-4-carboxylic acid amides as anticancer agents.
Topics: Amides; Animals; Antineoplastic Agents; Carboxylic Acids; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Mice; Molecular Conformation; Stereoisomerism; Structure-Activity Relationship; Thiazolidines; Tumor Cells, Cultured | 2010 |